Used as a starting material or intermediate in the development of drugs targeting the central nervous system, particularly in research on GABA-A receptors, which are involved in seizures, anxiety, and insomnia. This compound acts as a positive modulator of GABA-A receptors of subtypes α1, α2, α3, or α5 depending on the substructure, offering potential for development into sedatives or hypnotics that are more selective and have fewer side effects than benzodiazepines. In vitro and animal studies demonstrate anti-seizure and calming effects without severe respiratory inhibition, making it a key approach for designing safer and more effective new drugs.